

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.19193128 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.19193128 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.99516064 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.90080861 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.90080861 |
| 6 | cysteine metabolic process (GO:0006534) | 4.84179841 |
| 7 | lysine metabolic process (GO:0006553) | 4.79297915 |
| 8 | lysine catabolic process (GO:0006554) | 4.79297915 |
| 9 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.58609367 |
| 10 | mannose metabolic process (GO:0006013) | 4.39694967 |
| 11 | response to muramyl dipeptide (GO:0032495) | 4.29490689 |
| 12 | glyoxylate metabolic process (GO:0046487) | 4.28319606 |
| 13 | hemidesmosome assembly (GO:0031581) | 4.27738136 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 4.27632289 |
| 15 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.22119387 |
| 16 | bile acid biosynthetic process (GO:0006699) | 4.14275444 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.11355454 |
| 18 | regulation of cholesterol homeostasis (GO:2000188) | 3.96243872 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.92456546 |
| 20 | amino-acid betaine metabolic process (GO:0006577) | 3.90342807 |
| 21 | short-chain fatty acid metabolic process (GO:0046459) | 3.89749063 |
| 22 | cellular ketone body metabolic process (GO:0046950) | 3.85430826 |
| 23 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.82935294 |
| 24 | kynurenine metabolic process (GO:0070189) | 3.78917470 |
| 25 | fatty acid beta-oxidation (GO:0006635) | 3.75026785 |
| 26 | glutamate metabolic process (GO:0006536) | 3.72488587 |
| 27 | bile acid metabolic process (GO:0008206) | 3.71202084 |
| 28 | aspartate family amino acid catabolic process (GO:0009068) | 3.70676166 |
| 29 | fatty acid oxidation (GO:0019395) | 3.70257698 |
| 30 | 2-oxoglutarate metabolic process (GO:0006103) | 3.68647060 |
| 31 | homocysteine metabolic process (GO:0050667) | 3.62346549 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.61501774 |
| 33 | protein carboxylation (GO:0018214) | 3.61501774 |
| 34 | lipid oxidation (GO:0034440) | 3.60397645 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 3.58860647 |
| 36 | urea cycle (GO:0000050) | 3.58238493 |
| 37 | urea metabolic process (GO:0019627) | 3.58238493 |
| 38 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.58103387 |
| 39 | valine metabolic process (GO:0006573) | 3.57805456 |
| 40 | drug transmembrane transport (GO:0006855) | 3.56525030 |
| 41 | urate metabolic process (GO:0046415) | 3.51684722 |
| 42 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.51106706 |
| 43 | drug catabolic process (GO:0042737) | 3.50556433 |
| 44 | regulation of protein activation cascade (GO:2000257) | 3.49732994 |
| 45 | negative regulation of cell killing (GO:0031342) | 3.48811696 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.48811696 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46792044 |
| 48 | indole-containing compound catabolic process (GO:0042436) | 3.45724853 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 3.45724853 |
| 50 | tryptophan catabolic process (GO:0006569) | 3.45724853 |
| 51 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.44076272 |
| 52 | fatty acid catabolic process (GO:0009062) | 3.42065414 |
| 53 | high-density lipoprotein particle remodeling (GO:0034375) | 3.41975057 |
| 54 | cellular modified amino acid catabolic process (GO:0042219) | 3.35312955 |
| 55 | complement activation, alternative pathway (GO:0006957) | 3.34404954 |
| 56 | ketone body metabolic process (GO:1902224) | 3.33998879 |
| 57 | tryptophan metabolic process (GO:0006568) | 3.33900314 |
| 58 | ethanol oxidation (GO:0006069) | 3.32724613 |
| 59 | regulation of complement activation (GO:0030449) | 3.32582442 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 3.31635260 |
| 61 | carnitine metabolic process (GO:0009437) | 3.28235567 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28033694 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 3.27666797 |
| 64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.27497276 |
| 65 | negative regulation of fibrinolysis (GO:0051918) | 3.26949656 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 3.26160992 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.25832925 |
| 68 | phospholipid homeostasis (GO:0055091) | 3.24974291 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 3.23452251 |
| 70 | tricarboxylic acid metabolic process (GO:0072350) | 3.22698742 |
| 71 | fatty acid transmembrane transport (GO:1902001) | 3.22633855 |
| 72 | triglyceride homeostasis (GO:0070328) | 3.21727728 |
| 73 | acylglycerol homeostasis (GO:0055090) | 3.21727728 |
| 74 | biotin metabolic process (GO:0006768) | 3.21224059 |
| 75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.21096239 |
| 76 | cellular glucuronidation (GO:0052695) | 3.20967369 |
| 77 | negative regulation of sterol transport (GO:0032372) | 3.19325994 |
| 78 | negative regulation of cholesterol transport (GO:0032375) | 3.19325994 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.19054239 |
| 80 | positive regulation of glycolytic process (GO:0045821) | 3.18209755 |
| 81 | cellular amino acid catabolic process (GO:0009063) | 3.18182760 |
| 82 | tyrosine metabolic process (GO:0006570) | 3.15959410 |
| 83 | regulation of histone H3-K27 methylation (GO:0061085) | 3.13627048 |
| 84 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.12039556 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.10656080 |
| 86 | carnitine transport (GO:0015879) | 3.09609406 |
| 87 | amino-acid betaine transport (GO:0015838) | 3.09609406 |
| 88 | carnitine shuttle (GO:0006853) | 3.09234247 |
| 89 | regulation of bile acid biosynthetic process (GO:0070857) | 3.08587022 |
| 90 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.06523171 |
| 91 | exogenous drug catabolic process (GO:0042738) | 3.03758111 |
| 92 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.03739288 |
| 93 | plasma lipoprotein particle clearance (GO:0034381) | 3.03468832 |
| 94 | serine family amino acid metabolic process (GO:0009069) | 3.02943756 |
| 95 | regulation of fibrinolysis (GO:0051917) | 3.02297115 |
| 96 | macroautophagy (GO:0016236) | 3.01553913 |
| 97 | regulation of necroptotic process (GO:0060544) | 3.01464107 |
| 98 | reverse cholesterol transport (GO:0043691) | 3.00817874 |
| 99 | aromatic amino acid family metabolic process (GO:0009072) | 2.99658398 |
| 100 | response to mercury ion (GO:0046689) | 2.99374541 |
| 101 | organic acid catabolic process (GO:0016054) | 2.99084033 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 2.99084033 |
| 103 | ethanol metabolic process (GO:0006067) | 2.98499544 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98188824 |
| 105 | thymic T cell selection (GO:0045061) | 2.93808471 |
| 106 | drug transport (GO:0015893) | 2.91518696 |
| 107 | cell-substrate junction assembly (GO:0007044) | 2.88831506 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 2.87737560 |
| 109 | quaternary ammonium group transport (GO:0015697) | 2.87214277 |
| 110 | phospholipid efflux (GO:0033700) | 2.87129214 |
| 111 | carnitine transmembrane transport (GO:1902603) | 2.86868622 |
| 112 | benzene-containing compound metabolic process (GO:0042537) | 2.85894417 |
| 113 | desmosome organization (GO:0002934) | 2.84455675 |
| 114 | phosphate ion transport (GO:0006817) | 2.84306758 |
| 115 | cholesterol efflux (GO:0033344) | 2.83744328 |
| 116 | negative regulation of granulocyte differentiation (GO:0030853) | 2.83120168 |
| 117 | histone H3-K36 demethylation (GO:0070544) | 2.82319422 |
| 118 | sphingosine metabolic process (GO:0006670) | 2.80888606 |
| 119 | plasma lipoprotein particle remodeling (GO:0034369) | 2.80684658 |
| 120 | protein-lipid complex remodeling (GO:0034368) | 2.80684658 |
| 121 | macromolecular complex remodeling (GO:0034367) | 2.80684658 |
| 122 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.80437634 |
| 123 | intestinal cholesterol absorption (GO:0030299) | 2.80209899 |
| 124 | positive regulation of fatty acid oxidation (GO:0046321) | 2.80052093 |
| 125 | COPI coating of Golgi vesicle (GO:0048205) | 2.79067275 |
| 126 | Golgi transport vesicle coating (GO:0048200) | 2.79067275 |
| 127 | cellular response to virus (GO:0098586) | 2.78770799 |
| 128 | negative thymic T cell selection (GO:0045060) | 2.74737054 |
| 129 | protein localization to endosome (GO:0036010) | 2.72215466 |
| 130 | positive thymic T cell selection (GO:0045059) | 2.71763292 |
| 131 | leukocyte aggregation (GO:0070486) | 2.68953249 |
| 132 | germinal center formation (GO:0002467) | 2.67621773 |
| 133 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.67335629 |
| 134 | regulation of gamma-delta T cell activation (GO:0046643) | 2.63037091 |
| 135 | negative regulation of fatty acid transport (GO:2000192) | 2.59067581 |
| 136 | negative regulation of cell size (GO:0045792) | 2.54842555 |
| 137 | cellular response to ethanol (GO:0071361) | 2.51808887 |
| 138 | tolerance induction (GO:0002507) | 2.51691588 |
| 139 | negative T cell selection (GO:0043383) | 2.50723494 |
| 140 | opioid receptor signaling pathway (GO:0038003) | 2.49428994 |
| 141 | white fat cell differentiation (GO:0050872) | 2.45501786 |
| 142 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44854464 |
| 143 | cellular response to exogenous dsRNA (GO:0071360) | 2.44806403 |
| 144 | negative regulation of viral release from host cell (GO:1902187) | 2.43401678 |
| 145 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.43375571 |
| 146 | regulation of monocyte differentiation (GO:0045655) | 2.42819879 |
| 147 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41272537 |
| 148 | positive regulation of cholesterol efflux (GO:0010875) | 2.39535454 |
| 149 | negative regulation of innate immune response (GO:0045824) | 2.38999459 |
| 150 | B cell receptor signaling pathway (GO:0050853) | 2.38923697 |
| 151 | regulation of memory T cell differentiation (GO:0043380) | 2.38712860 |
| 152 | regulation of ARF protein signal transduction (GO:0032012) | 2.38388164 |
| 153 | negative regulation of T cell mediated immunity (GO:0002710) | 2.36820625 |
| 154 | regulation of antigen processing and presentation (GO:0002577) | 2.36237648 |
| 155 | T cell selection (GO:0045058) | 2.35219853 |
| 156 | sphingoid metabolic process (GO:0046519) | 2.33937658 |
| 157 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.32116063 |
| 158 | diol metabolic process (GO:0034311) | 2.30652842 |
| 159 | hypotonic response (GO:0006971) | 2.29713816 |
| 160 | retrograde transport, endosome to Golgi (GO:0042147) | 2.29066731 |
| 161 | response to laminar fluid shear stress (GO:0034616) | 2.28769428 |
| 162 | negative regulation of interleukin-6 production (GO:0032715) | 2.28229618 |
| 163 | regulation of extracellular matrix disassembly (GO:0010715) | 2.26695769 |
| 164 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.25996034 |
| 165 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.25960748 |
| 166 | wound healing, spreading of epidermal cells (GO:0035313) | 2.23670734 |
| 167 | regulation of plasminogen activation (GO:0010755) | 2.23393396 |
| 168 | negative regulation of interleukin-2 production (GO:0032703) | 2.23078436 |
| 169 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.22762665 |
| 170 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.21569431 |
| 171 | response to type I interferon (GO:0034340) | 2.21483500 |
| 172 | wound healing, spreading of cells (GO:0044319) | 2.21393893 |
| 173 | cell adhesion mediated by integrin (GO:0033627) | 2.20336350 |
| 174 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.19652462 |
| 175 | immunoglobulin mediated immune response (GO:0016064) | 2.19219545 |
| 176 | interferon-gamma secretion (GO:0072643) | 2.19192571 |
| 177 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.17833919 |
| 178 | type I interferon signaling pathway (GO:0060337) | 2.17445155 |
| 179 | cellular response to type I interferon (GO:0071357) | 2.17445155 |
| 180 | striated muscle atrophy (GO:0014891) | 2.16657513 |
| 181 | semaphorin-plexin signaling pathway (GO:0071526) | 2.16514870 |
| 182 | dosage compensation (GO:0007549) | 2.16241208 |
| 183 | glomerular basement membrane development (GO:0032836) | 2.15551835 |
| 184 | response to lipoprotein particle (GO:0055094) | 2.15062770 |
| 185 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.14609563 |
| 186 | regulation of necrotic cell death (GO:0010939) | 2.14542101 |
| 187 | surfactant homeostasis (GO:0043129) | 2.14132352 |
| 188 | pinocytosis (GO:0006907) | 2.13829709 |
| 189 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.13077744 |
| 190 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.12754477 |
| 191 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.12570642 |
| 192 | embryonic process involved in female pregnancy (GO:0060136) | 2.11362406 |
| 193 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.10873586 |
| 194 | activation of JUN kinase activity (GO:0007257) | 2.09492902 |
| 195 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.07156640 |
| 196 | protein hydroxylation (GO:0018126) | 2.06701636 |
| 197 | histone H3-K4 methylation (GO:0051568) | 2.06193028 |
| 198 | NIK/NF-kappaB signaling (GO:0038061) | 2.06136860 |
| 199 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.05130885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.22549747 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.27112387 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.61721159 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.47340986 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.96111317 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.38486182 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.34119492 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.29764484 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.22439562 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.12735160 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.81339394 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.79703617 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.71344051 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.44817179 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.40191145 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.36181710 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34803707 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.32843619 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.31143540 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25081096 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24381201 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.24063507 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.18099100 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10721676 |
| 25 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.09685097 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00129084 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98938843 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97368698 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.91375648 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90872668 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.88376549 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.85245986 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.84604815 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84428250 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83783811 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.78299657 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77300366 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.76184472 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76151350 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.74674405 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.71295007 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.67758320 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66655842 |
| 44 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.63731649 |
| 45 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60742203 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.59489786 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55827311 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55524977 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54855740 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.54101908 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53325477 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52452085 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52325305 |
| 54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51178672 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50884526 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50327384 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48843667 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47727409 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45539290 |
| 60 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45394397 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44634697 |
| 62 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.40417520 |
| 63 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40235075 |
| 64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39486002 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.39119882 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37412439 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36697965 |
| 68 | MYB_26560356_Chip-Seq_TH1_Human | 1.35625564 |
| 69 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34900895 |
| 70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.34491852 |
| 71 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33942311 |
| 72 | * P68_20966046_ChIP-Seq_HELA_Human | 1.33918233 |
| 73 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33908118 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33599639 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.32705254 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30431837 |
| 77 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30187728 |
| 78 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27526829 |
| 79 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27271909 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27076888 |
| 81 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25794916 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24884418 |
| 83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24409196 |
| 84 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23922723 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22280026 |
| 86 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21925172 |
| 87 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21283321 |
| 88 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20523142 |
| 89 | MYB_26560356_Chip-Seq_TH2_Human | 1.20298756 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19312955 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18145442 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17851155 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17529053 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17378648 |
| 95 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.17230991 |
| 96 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16887912 |
| 97 | ATF3_27146783_Chip-Seq_COLON_Human | 1.15473094 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15398045 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15196425 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14595088 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14396134 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13530435 |
| 103 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12045599 |
| 104 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11778038 |
| 105 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11696542 |
| 106 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11696542 |
| 107 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11471294 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10419691 |
| 109 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09545404 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07978740 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07953524 |
| 112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07907204 |
| 113 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07342753 |
| 114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07153800 |
| 115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06850956 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05829992 |
| 117 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05475567 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04006077 |
| 119 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.03719414 |
| 120 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03286843 |
| 121 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02890284 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02395707 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01561865 |
| 124 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00612209 |
| 125 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00560216 |
| 126 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99830140 |
| 127 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99830140 |
| 128 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99673686 |
| 129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98583378 |
| 130 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98359761 |
| 131 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97689900 |
| 132 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97161614 |
| 133 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96901374 |
| 134 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96568492 |
| 135 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95232573 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94914108 |
| 137 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94638374 |
| 138 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93132305 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93132305 |
| 140 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92417750 |
| 141 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91346978 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90365781 |
| 143 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89132491 |
| 144 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88665809 |
| 145 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87631568 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86682616 |
| 147 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86064694 |
| 148 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84338149 |
| 149 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84152525 |
| 150 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83547109 |
| 151 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.83425296 |
| 152 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.83134780 |
| 153 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82667708 |
| 154 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82301685 |
| 155 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81585816 |
| 156 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81063169 |
| 157 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80821739 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79669885 |
| 159 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.79485723 |
| 160 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.78138076 |
| 161 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76401292 |
| 162 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.76366297 |
| 163 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74887793 |
| 164 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.72460370 |
| 165 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.71638924 |
| 166 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.71237158 |
| 167 | CBP_21632823_ChIP-Seq_H3396_Human | 0.71213639 |
| 168 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.70407274 |
| 169 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70245049 |
| 170 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.69950701 |
| 171 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.69806852 |
| 172 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69287668 |
| 173 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68698424 |
| 174 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.68387466 |
| 175 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.68352158 |
| 176 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.68245385 |
| 177 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.68141859 |
| 178 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.67564843 |
| 179 | * AR_19668381_ChIP-Seq_PC3_Human | 0.66356137 |
| 180 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.66328516 |
| 181 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65804717 |
| 182 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.65311111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.16405291 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.65327445 |
| 3 | MP0005365_abnormal_bile_salt | 4.88705429 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.74858317 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.04674437 |
| 6 | MP0003252_abnormal_bile_duct | 3.31932395 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.99187394 |
| 8 | MP0003436_decreased_susceptibility_to | 2.91749032 |
| 9 | MP0009278_abnormal_bone_marrow | 2.91117946 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.79471250 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.74198086 |
| 12 | MP0005083_abnormal_biliary_tract | 2.66873937 |
| 13 | MP0003195_calcinosis | 2.56891551 |
| 14 | MP0005332_abnormal_amino_acid | 2.45443395 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.36809547 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.35249410 |
| 17 | MP0004043_abnormal_pH_regulation | 2.30914572 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.29422214 |
| 19 | MP0009840_abnormal_foam_cell | 2.24176987 |
| 20 | MP0004947_skin_inflammation | 2.13184804 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.08954173 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.06058119 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 2.05939478 |
| 24 | MP0003724_increased_susceptibility_to | 2.02588232 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.88247926 |
| 26 | MP0004130_abnormal_muscle_cell | 1.86282040 |
| 27 | MP0002796_impaired_skin_barrier | 1.86244472 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.75681097 |
| 29 | MP0003091_abnormal_cell_migration | 1.75586337 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.74470326 |
| 31 | MP0001849_ear_inflammation | 1.72776845 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.72366959 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.67425147 |
| 34 | MP0003868_abnormal_feces_composition | 1.60382500 |
| 35 | MP0008260_abnormal_autophagy | 1.57775819 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.56829618 |
| 37 | MP0000609_abnormal_liver_physiology | 1.56796307 |
| 38 | MP0002419_abnormal_innate_immunity | 1.56710995 |
| 39 | MP0000685_abnormal_immune_system | 1.52717886 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.52124097 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.48257992 |
| 42 | MP0005387_immune_system_phenotype | 1.48224287 |
| 43 | MP0001790_abnormal_immune_system | 1.48224287 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.47854115 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.47854115 |
| 46 | MP0001958_emphysema | 1.47701068 |
| 47 | MP0001661_extended_life_span | 1.45241161 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.44910265 |
| 49 | MP0001756_abnormal_urination | 1.44087999 |
| 50 | MP0003011_delayed_dark_adaptation | 1.38417759 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.37319486 |
| 52 | MP0001800_abnormal_humoral_immune | 1.36549971 |
| 53 | MP0005023_abnormal_wound_healing | 1.35865794 |
| 54 | MP0002723_abnormal_immune_serum | 1.35245130 |
| 55 | MP0001765_abnormal_ion_homeostasis | 1.33934745 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.31336833 |
| 57 | MP0001819_abnormal_immune_cell | 1.29782243 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.29651904 |
| 59 | MP0003329_amyloid_beta_deposits | 1.29573697 |
| 60 | MP0001835_abnormal_antigen_presentation | 1.26839445 |
| 61 | MP0005670_abnormal_white_adipose | 1.25960644 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 1.25693732 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.25454632 |
| 64 | MP0005409_darkened_coat_color | 1.23889261 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.20841987 |
| 66 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19780792 |
| 67 | MP0010678_abnormal_skin_adnexa | 1.19454168 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 1.17452242 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.16126737 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.15754078 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.15477662 |
| 72 | MP0005666_abnormal_adipose_tissue | 1.15195456 |
| 73 | MP0002933_joint_inflammation | 1.14766690 |
| 74 | MP0000604_amyloidosis | 1.13916003 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.13495364 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 1.12211529 |
| 77 | MP0004233_abnormal_muscle_weight | 1.11436498 |
| 78 | MP0005025_abnormal_response_to | 1.10630127 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.10477564 |
| 80 | MP0005187_abnormal_penis_morphology | 1.09232947 |
| 81 | MP0005164_abnormal_response_to | 1.07168389 |
| 82 | MP0005390_skeleton_phenotype | 1.06730129 |
| 83 | MP0000858_altered_metastatic_potential | 1.06528125 |
| 84 | MP0000716_abnormal_immune_system | 1.05945155 |
| 85 | MP0004782_abnormal_surfactant_physiolog | 1.05656836 |
| 86 | MP0002398_abnormal_bone_marrow | 1.05372535 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 1.05075099 |
| 88 | MP0003279_aneurysm | 1.04883805 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 1.03940585 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 1.03219371 |
| 91 | MP0008961_abnormal_basal_metabolism | 1.03131497 |
| 92 | MP0002405_respiratory_system_inflammati | 1.02926941 |
| 93 | MP0004858_abnormal_nervous_system | 1.02059796 |
| 94 | MP0000681_abnormal_thyroid_gland | 1.01934312 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 1.00221895 |
| 96 | MP0005464_abnormal_platelet_physiology | 1.00065928 |
| 97 | MP0003828_pulmonary_edema | 0.99824109 |
| 98 | MP0009764_decreased_sensitivity_to | 0.95844006 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.95326611 |
| 100 | MP0001851_eye_inflammation | 0.92635770 |
| 101 | MP0002090_abnormal_vision | 0.92626112 |
| 102 | MP0002166_altered_tumor_susceptibility | 0.92126201 |
| 103 | MP0003941_abnormal_skin_development | 0.91965759 |
| 104 | MP0005621_abnormal_cell_physiology | 0.91404393 |
| 105 | MP0002269_muscular_atrophy | 0.90607920 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.90336121 |
| 107 | MP0010368_abnormal_lymphatic_system | 0.89934664 |
| 108 | MP0002429_abnormal_blood_cell | 0.89701071 |
| 109 | MP0002722_abnormal_immune_system | 0.89311894 |
| 110 | MP0000678_abnormal_parathyroid_gland | 0.88859511 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.88640061 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.88517031 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.88078606 |
| 114 | MP0006082_CNS_inflammation | 0.87119185 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.86836055 |
| 116 | MP0000747_muscle_weakness | 0.86611819 |
| 117 | MP0006054_spinal_hemorrhage | 0.86585171 |
| 118 | MP0002971_abnormal_brown_adipose | 0.86032943 |
| 119 | MP0001853_heart_inflammation | 0.85904452 |
| 120 | MP0005220_abnormal_exocrine_pancreas | 0.85245651 |
| 121 | MP0005310_abnormal_salivary_gland | 0.85017497 |
| 122 | MP0008469_abnormal_protein_level | 0.84788504 |
| 123 | MP0004381_abnormal_hair_follicle | 0.84695041 |
| 124 | MP0001270_distended_abdomen | 0.84356853 |
| 125 | MP0005647_abnormal_sex_gland | 0.84244463 |
| 126 | MP0002006_tumorigenesis | 0.83996528 |
| 127 | MP0005503_abnormal_tendon_morphology | 0.82815537 |
| 128 | MP0002970_abnormal_white_adipose | 0.82802435 |
| 129 | MP0000383_abnormal_hair_follicle | 0.81430922 |
| 130 | MP0003786_premature_aging | 0.81424463 |
| 131 | MP0005535_abnormal_body_temperature | 0.81391621 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.80430573 |
| 133 | MP0010352_gastrointestinal_tract_polyps | 0.80143789 |
| 134 | MP0003656_abnormal_erythrocyte_physiolo | 0.79139352 |
| 135 | MP0000003_abnormal_adipose_tissue | 0.77618595 |
| 136 | MP0002060_abnormal_skin_morphology | 0.77464868 |
| 137 | MP0002234_abnormal_pharynx_morphology | 0.76744490 |
| 138 | MP0003566_abnormal_cell_adhesion | 0.76620809 |
| 139 | MP0004272_abnormal_basement_membrane | 0.76325443 |
| 140 | MP0008775_abnormal_heart_ventricle | 0.75256729 |
| 141 | MP0001764_abnormal_homeostasis | 0.73975878 |
| 142 | MP0002928_abnormal_bile_duct | 0.72443521 |
| 143 | MP0003690_abnormal_glial_cell | 0.71429244 |
| 144 | MP0004036_abnormal_muscle_relaxation | 0.70903985 |
| 145 | MP0000598_abnormal_liver_morphology | 0.69928627 |
| 146 | MP0001944_abnormal_pancreas_morphology | 0.69454490 |
| 147 | MP0005501_abnormal_skin_physiology | 0.68424485 |
| 148 | MP0005334_abnormal_fat_pad | 0.68242063 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.65514030 |
| 150 | MP0004084_abnormal_cardiac_muscle | 0.63193976 |
| 151 | MP0002009_preneoplasia | 0.62223681 |
| 152 | MP0004215_abnormal_myocardial_fiber | 0.61501318 |
| 153 | MP0009642_abnormal_blood_homeostasis | 0.61009489 |
| 154 | MP0002254_reproductive_system_inflammat | 0.60815160 |
| 155 | MP0003950_abnormal_plasma_membrane | 0.60639541 |
| 156 | MP0002896_abnormal_bone_mineralization | 0.60224884 |
| 157 | MP0005330_cardiomyopathy | 0.60098271 |
| 158 | MP0005451_abnormal_body_composition | 0.59229675 |
| 159 | MP0003183_abnormal_peptide_metabolism | 0.58489134 |
| 160 | MP0000467_abnormal_esophagus_morphology | 0.57943493 |
| 161 | MP0005275_abnormal_skin_tensile | 0.57368728 |
| 162 | MP0005448_abnormal_energy_balance | 0.56247433 |
| 163 | MP0001216_abnormal_epidermal_layer | 0.55548498 |
| 164 | MP0003953_abnormal_hormone_level | 0.55440140 |
| 165 | MP0003959_abnormal_lean_body | 0.54939945 |
| 166 | MP0003045_fibrosis | 0.54382913 |
| 167 | MP0005408_hypopigmentation | 0.53414501 |
| 168 | MP0005266_abnormal_metabolism | 0.51916768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.08999274 |
| 2 | Xanthomatosis (HP:0000991) | 4.81703206 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.71379530 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.37758586 |
| 5 | Ketoacidosis (HP:0001993) | 4.37409233 |
| 6 | Ketosis (HP:0001946) | 4.24782676 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.21480169 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.16755487 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.86320110 |
| 10 | Hyperglycinuria (HP:0003108) | 3.84894371 |
| 11 | Hyperglycinemia (HP:0002154) | 3.81977364 |
| 12 | Gout (HP:0001997) | 3.80763098 |
| 13 | Epidermoid cyst (HP:0200040) | 3.74935673 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.74508228 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.67121717 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.67121717 |
| 17 | Hyperammonemia (HP:0001987) | 3.66498716 |
| 18 | Thyroid-stimulating hormone excess (HP:0002925) | 3.46050830 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.42703732 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.40374999 |
| 21 | Myositis (HP:0100614) | 3.38647023 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.35564759 |
| 23 | Atrophic scars (HP:0001075) | 3.32646313 |
| 24 | Cervical subluxation (HP:0003308) | 3.30592184 |
| 25 | Abnormality of purine metabolism (HP:0004352) | 3.27201878 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.22525700 |
| 27 | Complement deficiency (HP:0004431) | 3.19259614 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.15980756 |
| 29 | Prolonged partial thromboplastin time (HP:0003645) | 3.15826833 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.15412299 |
| 31 | Fat malabsorption (HP:0002630) | 3.13450919 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.06816779 |
| 33 | Hypoglycemic seizures (HP:0002173) | 3.06291920 |
| 34 | Entropion (HP:0000621) | 3.05781551 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.03645446 |
| 36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.00966582 |
| 37 | Broad face (HP:0000283) | 2.99293357 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 2.96268991 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95385422 |
| 40 | Dysostosis multiplex (HP:0000943) | 2.95227299 |
| 41 | Orchitis (HP:0100796) | 2.83901283 |
| 42 | Colitis (HP:0002583) | 2.82614535 |
| 43 | Pustule (HP:0200039) | 2.80932927 |
| 44 | Skin nodule (HP:0200036) | 2.75570848 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.74669831 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.74669831 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.74669831 |
| 48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.71289219 |
| 49 | Hyperglycemia (HP:0003074) | 2.67399291 |
| 50 | Abnormality of glycolipid metabolism (HP:0010969) | 2.63849069 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.63849069 |
| 52 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.63849069 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.63096499 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.61727380 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59704513 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.59704513 |
| 57 | Hyperactive renin-angiotensin system (HP:0000841) | 2.57297656 |
| 58 | Myoglobinuria (HP:0002913) | 2.56323079 |
| 59 | Protrusio acetabuli (HP:0003179) | 2.55821746 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53421030 |
| 61 | Milia (HP:0001056) | 2.53049409 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.52924753 |
| 63 | Hyperuricemia (HP:0002149) | 2.50514593 |
| 64 | Increased purine levels (HP:0004368) | 2.50514593 |
| 65 | Symptomatic seizures (HP:0011145) | 2.45015571 |
| 66 | Spastic diplegia (HP:0001264) | 2.43045574 |
| 67 | Flat acetabular roof (HP:0003180) | 2.42238404 |
| 68 | Hyporeflexia of lower limbs (HP:0002600) | 2.42127749 |
| 69 | Acanthocytosis (HP:0001927) | 2.41559225 |
| 70 | Spinal cord lesions (HP:0100561) | 2.37743477 |
| 71 | Syringomyelia (HP:0003396) | 2.37743477 |
| 72 | Spondylolisthesis (HP:0003302) | 2.37390182 |
| 73 | Eczematoid dermatitis (HP:0000976) | 2.36180472 |
| 74 | Metabolic acidosis (HP:0001942) | 2.33924555 |
| 75 | Hypercholesterolemia (HP:0003124) | 2.31129487 |
| 76 | Hypokalemic alkalosis (HP:0001949) | 2.30818852 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.29214511 |
| 78 | Biconcave vertebral bodies (HP:0004586) | 2.28861727 |
| 79 | Malnutrition (HP:0004395) | 2.27487060 |
| 80 | Optic neuritis (HP:0100653) | 2.26809387 |
| 81 | Retrobulbar optic neuritis (HP:0100654) | 2.26809387 |
| 82 | Increased circulating renin level (HP:0000848) | 2.24726103 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 2.24519521 |
| 84 | Delayed CNS myelination (HP:0002188) | 2.23973663 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.21492549 |
| 86 | Cerebral aneurysm (HP:0004944) | 2.18744196 |
| 87 | Peritonitis (HP:0002586) | 2.18081711 |
| 88 | Cerebral inclusion bodies (HP:0100314) | 2.18071321 |
| 89 | Proximal tubulopathy (HP:0000114) | 2.17965729 |
| 90 | Hyperbilirubinemia (HP:0002904) | 2.17589653 |
| 91 | Loss of speech (HP:0002371) | 2.17519896 |
| 92 | Abnormality of chloride homeostasis (HP:0011422) | 2.17000808 |
| 93 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.16593263 |
| 94 | Gastrointestinal inflammation (HP:0004386) | 2.15495491 |
| 95 | Glomerulosclerosis (HP:0000096) | 2.15224255 |
| 96 | Myocardial infarction (HP:0001658) | 2.14938584 |
| 97 | Thin bony cortex (HP:0002753) | 2.14608491 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11975481 |
| 99 | Long eyelashes (HP:0000527) | 2.11394558 |
| 100 | Abnormality of the fingertips (HP:0001211) | 2.11106361 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10157485 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.10157485 |
| 103 | Abnormality of complement system (HP:0005339) | 2.10139723 |
| 104 | J-shaped sella turcica (HP:0002680) | 2.09951134 |
| 105 | Inflammation of the large intestine (HP:0002037) | 2.09833581 |
| 106 | Alkalosis (HP:0001948) | 2.09325820 |
| 107 | Steatorrhea (HP:0002570) | 2.08880988 |
| 108 | Abnormality of methionine metabolism (HP:0010901) | 2.08812240 |
| 109 | Right ventricular cardiomyopathy (HP:0011663) | 2.08694628 |
| 110 | Global brain atrophy (HP:0002283) | 2.05971096 |
| 111 | Thick nail (HP:0001805) | 2.04624952 |
| 112 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04420479 |
| 113 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04420479 |
| 114 | Turricephaly (HP:0000262) | 2.04223906 |
| 115 | Vertebral compression fractures (HP:0002953) | 2.03509034 |
| 116 | Oligodontia (HP:0000677) | 2.02947770 |
| 117 | Glucose intolerance (HP:0000833) | 2.01680852 |
| 118 | Aortic aneurysm (HP:0004942) | 2.01651080 |
| 119 | Disproportionate tall stature (HP:0001519) | 2.01178628 |
| 120 | Agammaglobulinemia (HP:0004432) | 2.01167028 |
| 121 | Arterial tortuosity (HP:0005116) | 1.99629865 |
| 122 | Panhypogammaglobulinemia (HP:0003139) | 1.99076587 |
| 123 | Protuberant abdomen (HP:0001538) | 1.98792611 |
| 124 | Mitral valve prolapse (HP:0001634) | 1.96318515 |
| 125 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.96271052 |
| 126 | Abnormality of serum amino acid levels (HP:0003112) | 1.96124363 |
| 127 | Hepatocellular carcinoma (HP:0001402) | 1.95332209 |
| 128 | Abnormal gallbladder morphology (HP:0012437) | 1.95083501 |
| 129 | Aortic dissection (HP:0002647) | 1.94710327 |
| 130 | Interstitial pulmonary disease (HP:0006530) | 1.94277544 |
| 131 | Focal segmental glomerulosclerosis (HP:0000097) | 1.93906957 |
| 132 | Persistence of primary teeth (HP:0006335) | 1.93485936 |
| 133 | Joint hemorrhage (HP:0005261) | 1.92223690 |
| 134 | Cholelithiasis (HP:0001081) | 1.89926302 |
| 135 | Tachypnea (HP:0002789) | 1.88697693 |
| 136 | Mitral regurgitation (HP:0001653) | 1.88264027 |
| 137 | Upper limb amyotrophy (HP:0009129) | 1.87488767 |
| 138 | Distal upper limb amyotrophy (HP:0007149) | 1.87488767 |
| 139 | Irritability (HP:0000737) | 1.87180177 |
| 140 | Vascular calcification (HP:0004934) | 1.86797363 |
| 141 | Vascular tortuosity (HP:0004948) | 1.86758956 |
| 142 | Mediastinal lymphadenopathy (HP:0100721) | 1.86699854 |
| 143 | Back pain (HP:0003418) | 1.86565442 |
| 144 | Pulmonary embolism (HP:0002204) | 1.86042666 |
| 145 | Granulocytopenia (HP:0001913) | 1.84941274 |
| 146 | Natal tooth (HP:0000695) | 1.84522091 |
| 147 | Dilatation of the ascending aorta (HP:0005111) | 1.84454711 |
| 148 | Esophageal varix (HP:0002040) | 1.83854917 |
| 149 | Neurofibrillary tangles (HP:0002185) | 1.82406197 |
| 150 | Blue sclerae (HP:0000592) | 1.81537351 |
| 151 | Cellulitis (HP:0100658) | 1.81022366 |
| 152 | Pigmentary retinal degeneration (HP:0001146) | 1.80744273 |
| 153 | Recurrent bacterial skin infections (HP:0005406) | 1.80644364 |
| 154 | Hydroxyprolinuria (HP:0003080) | 1.80602289 |
| 155 | Abnormality of proline metabolism (HP:0010907) | 1.80602289 |
| 156 | Resting tremor (HP:0002322) | 1.80361910 |
| 157 | Fragile skin (HP:0001030) | 1.80318686 |
| 158 | Dislocated radial head (HP:0003083) | 1.80159764 |
| 159 | Retinal atrophy (HP:0001105) | 1.80010703 |
| 160 | Hyperacusis (HP:0010780) | 1.79930141 |
| 161 | Abnormal gallbladder physiology (HP:0012438) | 1.79672831 |
| 162 | Cholecystitis (HP:0001082) | 1.79672831 |
| 163 | Hematochezia (HP:0002573) | 1.78963470 |
| 164 | Recurrent fungal infections (HP:0002841) | 1.78486695 |
| 165 | Abdominal distention (HP:0003270) | 1.77936899 |
| 166 | Lymphangioma (HP:0100764) | 1.77753830 |
| 167 | Hemoptysis (HP:0002105) | 1.77271237 |
| 168 | Arterial thrombosis (HP:0004420) | 1.76691337 |
| 169 | Cardiovascular calcification (HP:0011915) | 1.76211994 |
| 170 | Abnormal hair laboratory examination (HP:0003328) | 1.76044711 |
| 171 | Neonatal onset (HP:0003623) | 1.75919760 |
| 172 | Generalized aminoaciduria (HP:0002909) | 1.75572717 |
| 173 | Aortic regurgitation (HP:0001659) | 1.75476353 |
| 174 | Abnormality of the Achilles tendon (HP:0005109) | 1.75272397 |
| 175 | Vertebral arch anomaly (HP:0008438) | 1.74549730 |
| 176 | Aneurysm (HP:0002617) | 1.74356295 |
| 177 | Abnormality of vitamin metabolism (HP:0100508) | 1.74056919 |
| 178 | Recurrent abscess formation (HP:0002722) | 1.74052836 |
| 179 | Hemorrhage of the eye (HP:0011885) | 1.73722049 |
| 180 | Poikiloderma (HP:0001029) | 1.73148603 |
| 181 | Vomiting (HP:0002013) | 1.72647980 |
| 182 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.72495647 |
| 183 | Polygenic inheritance (HP:0010982) | 1.72290675 |
| 184 | Hand muscle atrophy (HP:0009130) | 1.71692342 |
| 185 | Rickets (HP:0002748) | 1.71602479 |
| 186 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.71097363 |
| 187 | Long toe (HP:0010511) | 1.70249152 |
| 188 | Metabolic alkalosis (HP:0200114) | 1.69486937 |
| 189 | Dysmetric saccades (HP:0000641) | 1.69012524 |
| 190 | Advanced eruption of teeth (HP:0006288) | 1.66820162 |
| 191 | Autoimmune thrombocytopenia (HP:0001973) | 1.64168435 |
| 192 | Genu recurvatum (HP:0002816) | 1.64039191 |
| 193 | Viral hepatitis (HP:0006562) | 1.63250467 |
| 194 | Abnormality of oral frenula (HP:0000190) | 1.63148306 |
| 195 | Nail dystrophy (HP:0008404) | 1.63127187 |
| 196 | Coarse hair (HP:0002208) | 1.62659200 |
| 197 | Abnormality of nail color (HP:0100643) | 1.62539479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.24051605 |
| 2 | INSRR | 2.96217434 |
| 3 | ERN1 | 2.86802613 |
| 4 | MAP3K2 | 2.79597126 |
| 5 | SIK1 | 2.75827519 |
| 6 | MAP2K3 | 2.63894100 |
| 7 | BCKDK | 2.24032286 |
| 8 | MAP3K10 | 2.21973713 |
| 9 | PDK4 | 2.21760018 |
| 10 | PDK3 | 2.21760018 |
| 11 | RIPK1 | 2.18657536 |
| 12 | MAP4K1 | 2.08159663 |
| 13 | FGFR2 | 2.06303607 |
| 14 | MAP2K2 | 2.03596960 |
| 15 | MST1R | 1.98333592 |
| 16 | WNK4 | 1.97721756 |
| 17 | LATS1 | 1.96844179 |
| 18 | PKN2 | 1.81774818 |
| 19 | OXSR1 | 1.73579989 |
| 20 | PRKD2 | 1.69946068 |
| 21 | JAK3 | 1.62796931 |
| 22 | CDC42BPA | 1.61935506 |
| 23 | MAP3K14 | 1.61902341 |
| 24 | ICK | 1.56877502 |
| 25 | TRIB3 | 1.54030932 |
| 26 | PAK3 | 1.52253360 |
| 27 | TBK1 | 1.47023915 |
| 28 | STK39 | 1.46637509 |
| 29 | ADRBK2 | 1.45857647 |
| 30 | PTK6 | 1.44812222 |
| 31 | IRAK3 | 1.42637367 |
| 32 | FGFR4 | 1.41919150 |
| 33 | SCYL2 | 1.39014952 |
| 34 | SMG1 | 1.37163854 |
| 35 | MAP2K4 | 1.36692489 |
| 36 | TTN | 1.36066865 |
| 37 | WNK3 | 1.32669538 |
| 38 | MAP3K7 | 1.32014474 |
| 39 | KSR2 | 1.31677881 |
| 40 | IKBKE | 1.30312792 |
| 41 | TAOK3 | 1.28978945 |
| 42 | EPHA4 | 1.28890261 |
| 43 | NEK9 | 1.28306423 |
| 44 | PRPF4B | 1.25616138 |
| 45 | SGK3 | 1.25304081 |
| 46 | PDK2 | 1.20771300 |
| 47 | MET | 1.18125829 |
| 48 | ZAP70 | 1.16724503 |
| 49 | DAPK2 | 1.11307775 |
| 50 | MAP3K3 | 1.11025795 |
| 51 | BTK | 1.10368448 |
| 52 | MARK2 | 1.10074719 |
| 53 | SIK3 | 1.08409303 |
| 54 | FES | 1.05820632 |
| 55 | LMTK2 | 1.05269465 |
| 56 | CAMK1D | 1.05041006 |
| 57 | MAPK15 | 1.02421988 |
| 58 | RPS6KA2 | 1.01780584 |
| 59 | NUAK1 | 1.01138995 |
| 60 | FER | 1.01025183 |
| 61 | PRKAA2 | 1.00411235 |
| 62 | CAMK1G | 0.99501938 |
| 63 | ERBB4 | 0.99427919 |
| 64 | SGK2 | 0.98962435 |
| 65 | PDGFRA | 0.98951789 |
| 66 | SGK223 | 0.98265497 |
| 67 | SGK494 | 0.98265497 |
| 68 | RIPK4 | 0.97857490 |
| 69 | PRKCH | 0.97679875 |
| 70 | RET | 0.96558554 |
| 71 | NTRK1 | 0.95490781 |
| 72 | ITK | 0.92449625 |
| 73 | MAP3K4 | 0.92139802 |
| 74 | TGFBR2 | 0.90789621 |
| 75 | TNK2 | 0.90577219 |
| 76 | EPHA2 | 0.87260427 |
| 77 | MAP2K6 | 0.85121703 |
| 78 | NEK1 | 0.84579572 |
| 79 | TYRO3 | 0.84122739 |
| 80 | PAK4 | 0.82973846 |
| 81 | FGFR1 | 0.82948930 |
| 82 | PRKAA1 | 0.82474061 |
| 83 | STK38 | 0.82301629 |
| 84 | JAK2 | 0.80961901 |
| 85 | HCK | 0.80819953 |
| 86 | LRRK2 | 0.80711741 |
| 87 | EEF2K | 0.80613132 |
| 88 | MTOR | 0.80565381 |
| 89 | HIPK2 | 0.80382062 |
| 90 | WNK1 | 0.80156375 |
| 91 | YES1 | 0.79868742 |
| 92 | IKBKB | 0.79731500 |
| 93 | RPS6KL1 | 0.79442596 |
| 94 | RPS6KC1 | 0.79442596 |
| 95 | AKT3 | 0.78509158 |
| 96 | PHKG2 | 0.78372391 |
| 97 | PHKG1 | 0.78372391 |
| 98 | MAP3K6 | 0.77451516 |
| 99 | NEK6 | 0.72877103 |
| 100 | CDK9 | 0.72397422 |
| 101 | TRPM7 | 0.72195515 |
| 102 | JAK1 | 0.71958935 |
| 103 | CSF1R | 0.71193004 |
| 104 | GRK6 | 0.70615601 |
| 105 | PDPK1 | 0.70436753 |
| 106 | BRD4 | 0.70346074 |
| 107 | DYRK1B | 0.69687831 |
| 108 | MAP2K1 | 0.69370060 |
| 109 | LCK | 0.69317172 |
| 110 | BLK | 0.68975332 |
| 111 | RPS6KA6 | 0.68787759 |
| 112 | GSK3A | 0.68740819 |
| 113 | PTK2 | 0.67726220 |
| 114 | EPHB1 | 0.67105131 |
| 115 | CSK | 0.66408762 |
| 116 | CDK12 | 0.66067830 |
| 117 | MAPK7 | 0.65712550 |
| 118 | FGFR3 | 0.65353680 |
| 119 | PDGFRB | 0.65005412 |
| 120 | NTRK3 | 0.64704960 |
| 121 | PRKACG | 0.64235858 |
| 122 | MAP3K13 | 0.64220984 |
| 123 | MAP3K11 | 0.63628907 |
| 124 | SGK1 | 0.63494051 |
| 125 | MAP3K9 | 0.62562065 |
| 126 | PRKD3 | 0.61975738 |
| 127 | PRKD1 | 0.61790657 |
| 128 | PDK1 | 0.61516300 |
| 129 | IRAK1 | 0.59285854 |
| 130 | TAOK1 | 0.59258174 |
| 131 | FGR | 0.55580785 |
| 132 | SIK2 | 0.54800841 |
| 133 | MAPK11 | 0.54657501 |
| 134 | TEC | 0.53234524 |
| 135 | ADRBK1 | 0.52687813 |
| 136 | EGFR | 0.52680923 |
| 137 | PIM2 | 0.51707108 |
| 138 | EPHA3 | 0.50988114 |
| 139 | IRAK4 | 0.50172298 |
| 140 | PAK6 | 0.49796088 |
| 141 | CDK4 | 0.49496376 |
| 142 | CDK6 | 0.49139711 |
| 143 | MAPKAPK2 | 0.48905534 |
| 144 | STK38L | 0.48761679 |
| 145 | DDR2 | 0.48130441 |
| 146 | TXK | 0.47172514 |
| 147 | TYK2 | 0.46491935 |
| 148 | CHUK | 0.46237260 |
| 149 | PAK2 | 0.46208134 |
| 150 | STK11 | 0.45724548 |
| 151 | CAMKK1 | 0.45159238 |
| 152 | PRKCZ | 0.45122168 |
| 153 | BMX | 0.44316955 |
| 154 | STK3 | 0.44082244 |
| 155 | RPS6KA3 | 0.43875506 |
| 156 | MAP3K1 | 0.42267525 |
| 157 | STK10 | 0.41969770 |
| 158 | ERBB2 | 0.41735546 |
| 159 | KSR1 | 0.41664706 |
| 160 | TIE1 | 0.41188703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.59835431 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.35558413 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.27869454 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83484655 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71552695 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61158796 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.50935610 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49598874 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40539925 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.36262495 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.35267198 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.29066383 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.17261453 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.15692934 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.12708929 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.98743336 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.91749653 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.89296488 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82172153 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.81315142 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.81046253 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.80488562 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80166573 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.79815490 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79442381 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.65715318 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.61450992 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57290957 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56719859 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.55345748 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53861928 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.52151864 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51854216 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.47939865 |
| 35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.47925972 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.47434596 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46760659 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45381426 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45307110 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.42892101 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.42232071 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41739654 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39747363 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39165406 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38968204 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37462481 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.37170823 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34646678 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34596433 |
| 50 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33980417 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33544837 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32259529 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.31479646 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 1.29117331 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28685336 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27884487 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25022701 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22719694 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.21920087 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21422895 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21418891 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 1.20591787 |
| 63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.19786276 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18810488 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 1.17608015 |
| 66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17084586 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.15523181 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15504413 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 1.13839528 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 1.12205172 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12192068 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11545335 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11127522 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11078857 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11023872 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09777894 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08509019 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08473452 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07500833 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07448843 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07358410 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06034114 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05487060 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 1.04025249 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 1.03865043 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03135211 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00368185 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 1.00053075 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98981757 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.97557304 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97360300 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97071579 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96858130 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.95265587 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.93244923 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93033478 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92748558 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91684431 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.90661926 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89145324 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88802460 |
| 102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87822739 |
| 103 | Measles_Homo sapiens_hsa05162 | 0.87333162 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86637930 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86363984 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85605193 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84344447 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84292218 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83406171 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82461762 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81276422 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79494371 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79464832 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79016676 |
| 115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78840976 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78568711 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76882638 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.76765001 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76755386 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.76047205 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73738653 |
| 122 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72000161 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71816688 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71204601 |
| 125 | Asthma_Homo sapiens_hsa05310 | 0.71157408 |
| 126 | Legionellosis_Homo sapiens_hsa05134 | 0.70634978 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70550868 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70488397 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.70260495 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.69355007 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68230170 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66886941 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66711939 |
| 134 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65870891 |
| 135 | Endocytosis_Homo sapiens_hsa04144 | 0.64252046 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64134926 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63533626 |
| 138 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61971548 |
| 139 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61339541 |
| 140 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61118069 |
| 141 | Glioma_Homo sapiens_hsa05214 | 0.60254402 |
| 142 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59818903 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59623212 |
| 144 | Prostate cancer_Homo sapiens_hsa05215 | 0.58627764 |
| 145 | Insulin secretion_Homo sapiens_hsa04911 | 0.58555341 |
| 146 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58131956 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57965073 |
| 148 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57888646 |
| 149 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55722237 |
| 150 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55668655 |
| 151 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53762706 |
| 152 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52492664 |
| 153 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51190059 |
| 154 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50389506 |
| 155 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49083881 |
| 156 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46353197 |
| 157 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45427038 |
| 158 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43244852 |
| 159 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40681146 |
| 160 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40360604 |
| 161 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39507590 |
| 162 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37866610 |
| 163 | Mineral absorption_Homo sapiens_hsa04978 | 0.37172810 |
| 164 | Renin secretion_Homo sapiens_hsa04924 | 0.35249112 |
| 165 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31182246 |
| 166 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30539428 |
| 167 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30358199 |
| 168 | Phototransduction_Homo sapiens_hsa04744 | 0.28913582 |
| 169 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27759911 |
| 170 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27713424 |
| 171 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27663131 |
| 172 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27422361 |
| 173 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26888543 |
| 174 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25659827 |
| 175 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25188522 |
| 176 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24681548 |
| 177 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23535076 |
| 178 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23241952 |
| 179 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23213934 |
| 180 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23056208 |
| 181 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20349549 |
| 182 | Salivary secretion_Homo sapiens_hsa04970 | 0.16954425 |
| 183 | Long-term potentiation_Homo sapiens_hsa04720 | 0.15711724 |
| 184 | GABAergic synapse_Homo sapiens_hsa04727 | 0.15013734 |
| 185 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.14786125 |
| 186 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.14722591 |

